Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies

OBJECTIVE: Episodes of major depressive disorder (MDD) characterized by high levels of anxiety symptoms are less likely to respond to some forms of antidepressant treatment (ADT). This report examines the effects of adjunctive brexpiprazole on depressive symptoms among patients with MDD and anxiety...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuropsychiatr Dis Treat
Asıl Yazarlar: Thase, Michael E, Weiller, Emmanuelle, Zhang, Peter, Weiss, Catherine, McIntyre, Roger S
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2018
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6305164/
https://ncbi.nlm.nih.gov/pubmed/30587996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S185815
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller